Article
Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies
4 Nov 2009
Abstract excerpt
Hepatitis B virus (HBV) infections represent a global health problem, since these account for 350 million chronic infections worldwide that result in 500,000-700,000 deaths each year. Control of viral replication and HBV-related disease and mortality are of utmost importance. Because the currently available antiviral therapies all have major limitations, new strategies to treat chronic HBV infection are eagerly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
